Identification of an HLA-DR-restricted peptide epitope with a promiscuous binding pattern derived from the cancer testis antigen HOM-MEL-40/SSX2

International Journal of Cancer. Journal International Du Cancer
Frank NeumannMichael Pfreundschuh

Abstract

The SSX2 gene encodes the tumor-specific antigen HOM-MEL-40/SSX2 expressed in a broad spectrum of tumors of different origin, against which humoral and CD8+ T-cell-mediated MHC-I-restricted responses have been demonstrated. Searching for promiscuous MHC-II-restricted peptides that might be suitable as a CD4+ stimulating vaccine for many patients, we used the SYFPEITHI algorithm and identified a HOM-MEL-40/SSX2-derived pentadecamer epitope (p45-59) that induced specific CD4+ T-cell responses restricted by the HLA-DRB1 subtypes *0701, *1101 and *1302 that have a cumulative prevalence of approximately 25% in the Caucasian population. The CD4+-mediated response against p45-59 and its DR restriction was demonstrated by inhibition with anti-CD4 and HLA-DR antibodies, respectively, and by blocking experiments using HLA-specific antibodies. The natural processing and presentation of p45-59 was demonstrated by recognition of the SSX2+ melanoma cell line Me 275 as well as autologous and allogeneic dendritic cells pulsed with whole-protein SSX2 by T cells with specificity for p45-59. p45-59 was able to induce responses in 3/6 breast cancer patients and 1/5 healthy controls. No correlation was found between CD4+ T-cell responses against p4...Continue Reading

Citations

Oct 15, 2009·Applied Microbiology and Biotechnology·Chung-Jr HuangCarl A Batt
Sep 15, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ulrike GerdemannAnn M Leen
Sep 10, 2011·Journal of Immunotherapy·Heath A Smith, Douglas G McNeel
Jan 11, 2013·Open Biology·Atanas Patronov, Irini Doytchinova
May 17, 2006·Clinical and Experimental Pharmacology & Physiology·P A MacaryX Dai
Oct 13, 2007·Protein Expression and Purification·Chung-Jr HuangCarl A Batt
Oct 29, 2010·Clinical & Developmental Immunology·Heath A Smith, Douglas G McNeel
Sep 4, 2010·British Journal of Haematology·Adnan AlahmadMichael Pfreundschuh
Nov 21, 2015·Human Immunology·Satarudra Prakash Singh, Bhartendu Nath Mishra
Nov 24, 2007·Journal of Proteome Research·Uthaman Gowthaman, Javed N Agrewala
Oct 14, 2005·Expert Review of Vaccines·Adriana BazAnne Kelso
Oct 9, 2009·Expert Review of Proteomics·Uthaman Gowthaman, Javed N Agrewala
Feb 25, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maurizio Zanetti
Jan 8, 2014·Experimental and Therapeutic Medicine·Guilan ShiShuren Zhang
Jul 8, 2020·Cancers·Magalie DossetMaurizio Zanetti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

International Journal of Cancer. Journal International Du Cancer
Gerhard HeldMichael Pfreundschuh
Proceedings of the National Academy of Sciences of the United States of America
U SahinM Pfreundschuh
© 2021 Meta ULC. All rights reserved